A. Pello

发表

The Prognostic Value of High-Sensitive Troponin I in Stable Coronary Artery Disease Depends on Age and Other Clinical Variables

J. Egido, L. Blanco-Colio, J. Martín-Ventura, 2015, Cardiology.

Important abnormalities of bone mineral metabolism are present in patients with coronary artery disease with a mild decrease of the estimated glomerular filtration rate

F. Rodríguez‐Artalejo, A. Ortiz, J. Egido, 2016, Journal of Bone and Mineral Metabolism.

Design and rationale of a multicentre, randomised, double-blind, placebo-controlled clinical trial to evaluate the effect of vitamin D on ventricular remodelling in patients with anterior myocardial infarction: the VITamin D in Acute Myocardial Infarction (VITDAMI) trial

B. Ibáñez, J. Egido, I. Mahíllo-Fernández, 2016, BMJ Open.

Parathormone levels are independently associated with the presence of left ventricular hypertrophy in patients with coronary artery disease

J. Egido, I. Mahíllo-Fernández, L. Blanco-Colio, 2015, The journal of nutrition, health & aging.

Important abnormalities of bone mineral metabolism are present in patients with coronary artery disease with mild decrease of estimated glomerular filtration rate Short title: CKD-MBD in coronary artery disease patients

F. Rodríguez‐Artalejo, J. Egido, I. Mahíllo-Fernández, 2016 .

N-Terminal Pro-Brain Natriuretic Peptide Plasma Levels Are Associated with Intermediate-Term Follow-Up Cancer in Coronary Patients

J. Egido, I. Mahíllo-Fernández, L. Blanco-Colio, 2021, Journal of clinical medicine.

N-Terminal Pro-Brain Natriuretic Peptide Is Associated with a Future Diagnosis of Cancer in Patients with Coronary Artery Disease

J. Egido, I. Mahíllo-Fernández, L. Blanco-Colio, 2015, PloS one.

Circulating fibroblast growth factor‐23 plasma levels predict adverse cardiovascular outcomes in patients with diabetes mellitus with coronary artery disease

B. Fernández-Fernández, J. Egido, I. Mahíllo-Fernández, 2016, Diabetes/metabolism research and reviews.

NT-proBNP Levels Influence the Prognostic Value of Mineral Metabolism Biomarkers in Coronary Artery Disease

J. Egido, I. Mahíllo-Fernández, L. Blanco-Colio, 2022, Journal of clinical medicine.

Sun exposure influences the prognostic power of components of mineral metabolism in patients with coronary artery disease.

J. Egido, E. González-Parra, Ó. Lorenzo, 2017, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Galectin-3 is Associated with Cardiovascular Events in Post-Acute Coronary Syndrome Patients with Type-2 Diabetes

J. Egido, L. Blanco-Colio, J. Martín-Ventura, 2020, Journal of clinical medicine.

Parathormone levels add prognostic ability to N‐terminal pro‐brain natriuretic peptide in stable coronary patients

J. Egido, I. Mahíllo-Fernández, L. Blanco-Colio, 2021, ESC heart failure.

The other side of anticoagulant therapy

J. Tuñón, A. Pello, C. García-Talavera, 2019, REC: CardioClinics.

Ergonovine provocative test in Caucasian patients with left ventricular apical ballooning syndrome.

F. Fernández‐Avilés, M. Martínez‐Sellés, A. Pello, 2010, International journal of cardiology.

Plasma Levels of Monocyte Chemoattractant Protein-1, n-Terminal Fragment of Brain Natriuretic Peptide and Calcidiol Are Independently Associated with the Complexity of Coronary Artery Disease

J. Egido, L. Blanco-Colio, J. Martín-Ventura, 2016, PloS one.

[Impact of plasma pro-B-type natriuretic peptide amino-terminal and galectin-3 levels on the predictive capacity of the LIPID Clinical Risk Scale in stable coronary disease].

F. Rodríguez‐Artalejo, J. Egido, I. Mahíllo-Fernández, 2015, Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis.

Impact of the COVID-19 pandemic on the diagnosis, management and prognosis of infective endocarditis

F. Domínguez, A. H. Torres, E. Gutierrez-Carretero, 2020, Clinical Microbiology and Infection.

Dipyridamole echocardiography test in patients with normal or near normal coronary arteries.

M. Martínez‐Sellés, A. Pello, T. Datino, 2005, European heart journal.

Spasm provocative test in troponin-positive patients with acute chest pain and no significant coronary artery disease.

F. Fernández‐Avilés, M. Martínez‐Sellés, A. Pello, 2010, European heart journal.

Impacto de los niveles plasmáticos de pro-péptido natriurético tipo B aminoterminal, proteína quimiotáctica de monocitos-1 y galectina 3 en la capacidad predictiva de eventos de la escala clínica LIPID en la enfermedad coronaria estable

F. Rodríguez‐Artalejo, J. Egido, I. Mahíllo-Fernández, 2015 .

Differential profile in inflammatory and mineral metabolism biomarkers in patients with ischemic heart disease without classical coronary risk factors.

J. Egido, I. Mahíllo-Fernández, L. Blanco-Colio, 2015, Journal of cardiology.

[Percutaneous aortic valve implantation: initial experience in Spain].

M. García-Fernández, Eulogio J. García, Á. Pinto, 2008, Revista espanola de cardiologia.

Predictors of coronary spasm in patients with chest pain and no significant coronary stenosis.

M. Martínez‐Sellés, A. Pello, T. Datino, 2010, International journal of cardiology.

Coexistence of Low Vitamin D and High Fibroblast Growth Factor-23 Plasma Levels Predicts an Adverse Outcome in Patients with Coronary Artery Disease

F. Rodríguez‐Artalejo, J. Egido, I. Mahíllo-Fernández, 2014, PloS one.

Mural Endocarditis: The GAMES Registry Series and Review of the Literature

J. Bermejo, H. Rodríguez-Abella, Mireia Blé, 2021, Infectious Diseases and Therapy.

Comparison of 3 Predictive Clinical Risk Scores in 603 Patients with Stable Coronary Artery Disease.

I. Mahíllo-Fernández, Ó. Lorenzo, J. Tuñón, 2017, Texas Heart Institute journal.

The role of bioimpedance analysis in overweight and obese patients with acute heart failure: a pilot study

E. González-Parra, J. Tuñón, Á. Aceña, 2023, ESC heart failure.

Dapagliflozin Improved Cardiac Function and Structure in Diabetic Patients with Preserved Ejection Fraction: Results of a Single Centre, Observational Prospective Study

M. Orejas, J. Tuñón, A. Pello, 2023, Journal of clinical medicine.

Fibroblast growth factor 23 independently predicts adverse outcomes after an acute coronary syndrome

Ó. Lorenzo, J. Tuñón, Á. Aceña, 2023, ESC heart failure.

Serum Biomarkers and Their Association with Myocardial Function and Exercise Capacity in Cardiac Transthyretin Amyloidosis

J. Tuñón, Sandra Gómez-Talavera, Á. Aceña, 2024, Journal of cardiovascular development and disease.